|Date & Time||13-17 February 2023|
Pg. de Sant Joan, 108, 08037
DISCOVER THE LANDSCAPE OF TRANSLATIONAL MEDICINE IN A 5 DAY COURSE!
Interested in discovering the landscape of Translational Medicine? Want to learn about the job profiles of scientists in Industry and other sectors?
Then join the 2023 TMex winter school!
The TMex (“Translational Medicine Explained)” Winter School consists of an introductory e learning (~12 hours student investment time) followed by a 5-day face-to-face workshop on 13-17 February 2023. The course is intended for PhD/MD students in the second half of their PhD and postdocs who are involved in biomedical research.
The course is kindly supported by La Caixa Foundation and the Vall d’Hebron Research Institute (VHIR) and will be hosted in one of Barcelona’s great Catalan Modernisme gems: the Palau Macaya!
The course covers a variety of activities, including a drug discovery game, elevator pitches, group work and lectures. Experts in the field from academia and industry will be addressing essential elements of the translational pipeline such as target validation, target product profiles, quality and reproducibility, clinical trials, regulatory support, patients driven research and personalized medicine. Several innovation sessions will take place, covering the business canvas model, critical success factor in the translational pathway and how to communicate your research to society.
Two free (0€) seats are available for candidates from EU-13 countries (Bulgaria (BG), Croatia (HR), Cyprus (CY), Czech Republic (CZ), Estonia (EE), Hungary (HU), Latvia (LV), Lithuania (LT), Malta (MT), Poland (PL),
Romania (RO), Slovakia (SK) and Slovenia (SI)), Latin America and Africa. All seats have been attributed
Registration is open since September 19, 2022. There are only 30 seats, so we recommend applying early (first come, first served). The registration will close when all seats have been filled. You will need to submit a biosketch and a motivation letter which will be reviewed by a selection committee.
<< TMex preliminary agenda
- Maria Borrell Pages, Senior Researcher and Patient Advocate, Sant Pau Hospital
- Keith Williams, Director, KW Drug Developments
- Susana Otero, Head of group Epidemiology and Public Health, VHIR
- Piret Pajula & Jake Fairnie, EATRIS communications team
- Eva Colás Ortega, Principal researcher at VHIR, CSO and Co-founder at MiMARK
- Ramón Martí Seves, Head neuromuscular and mitochondrial pathology, VHIR
- Björn Gerlach, Partner and COO, PAASP